Sprout

CallFixie is an online platform that connects customers with a network of qualified tradespeople across Australia. This free service allows users to post jobs without incurring sign-up or subscription fees, making it accessible for anyone in need of home repair and maintenance services. Customers can easily find and receive quotes from a wide range of trades, referred to as "Fixies," through a user-friendly website and mobile applications. By streamlining the process of finding reliable service providers, CallFixie simplifies the experience of managing home repair tasks, ensuring that jobs of any size can be efficiently sorted.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, specializing in the development and commercialization of late-stage medicines for conditions primarily in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company is known for its product VELTASSA, a potassium binder designed to treat hyperkalemia. Relypsa focuses on discovering and developing non-absorbed polymeric drugs that address cardiovascular and renal diseases, particularly conditions that are often overlooked or undertreated. Established in 2007, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, specializing in the development and commercialization of late-stage medicines for conditions primarily in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company is known for its product VELTASSA, a potassium binder designed to treat hyperkalemia. Relypsa focuses on discovering and developing non-absorbed polymeric drugs that address cardiovascular and renal diseases, particularly conditions that are often overlooked or undertreated. Established in 2007, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, specializing in the development and commercialization of late-stage medicines for conditions primarily in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company is known for its product VELTASSA, a potassium binder designed to treat hyperkalemia. Relypsa focuses on discovering and developing non-absorbed polymeric drugs that address cardiovascular and renal diseases, particularly conditions that are often overlooked or undertreated. Established in 2007, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, specializing in the development and commercialization of late-stage medicines for conditions primarily in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company is known for its product VELTASSA, a potassium binder designed to treat hyperkalemia. Relypsa focuses on discovering and developing non-absorbed polymeric drugs that address cardiovascular and renal diseases, particularly conditions that are often overlooked or undertreated. Established in 2007, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

TradeBeam is a provider of Global Trade Management software and services that focuses on streamlining global trading processes for enterprises and their partners. The company offers an integrated solution that enhances import and export compliance and visibility, encompassing inventory management, shipment tracking, and supply chain event management. Additionally, TradeBeam provides global trade finance solutions, including management for open accounts and letters of credit, facilitating smoother international trade operations.

Calix Inc., established in 1999 and headquartered in San Jose, California, specializes in providing cloud-based platforms and software systems to communication service providers (CSPs) worldwide. Its offerings include Calix Cloud, an analytics platform for CSP professionals; Calix Marketing Cloud and Support Cloud for marketing and customer support teams respectively; Experience eXtensible Operating System for residential, business, and mobile subscribers; and Access eXtensible Operating System tailored for access networks. These platforms enable CSPs to simplify their operations, deliver advanced broadband services, and enhance subscriber experiences, ultimately driving growth in subscriber acquisition, loyalty, and revenue. Calix serves customers across the United States, Middle East, Europe, Asia Pacific, and other regions, primarily through its direct sales force and resellers.

CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.

Affymax, Inc. is a biopharmaceutical company based in New York, founded in 2001, that focuses on developing novel peptide-based therapeutics aimed at treating serious and life-threatening conditions. The company's primary product, OMONTYS, is an injection designed to treat anemia associated with chronic kidney disease in adult patients on dialysis. OMONTYS is notable for being the only once-monthly erythropoiesis-stimulating agent available for this patient population in the United States. At one point, a New Drug Application for peginesatide, the active component of OMONTYS, was under review by the U.S. Food and Drug Administration, but the company currently does not have significant operations.

Labcyte Inc., founded in 2000 and based in San Jose, California, specializes in developing acoustic droplet ejection (ADE) technology for various applications in the life sciences. The company's innovative approach uses focused beams of acoustic energy to precisely dispense nanoliter-scale droplets of fluid from one plate to another, enabling high accuracy at low volumes and reducing consumables costs. Labcyte's products include automation systems, laboratory workstations, and control software, which are utilized in drug discovery, genomics research, cancer research, and personalized medicine. The company operates as a subsidiary of Beckman Coulter, Inc., with additional offices across multiple countries including Canada, the United Kingdom, Australia, India, South Korea, China, Hong Kong, Japan, Singapore, and Taiwan.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, specializing in the development and commercialization of late-stage medicines for conditions primarily in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company is known for its product VELTASSA, a potassium binder designed to treat hyperkalemia. Relypsa focuses on discovering and developing non-absorbed polymeric drugs that address cardiovascular and renal diseases, particularly conditions that are often overlooked or undertreated. Established in 2007, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Barricaid is a medical device company that focuses on developing innovative solutions to prevent repeat disc herniation in patients who have undergone back surgery. The company's flagship product is a bone-anchored implant designed to reduce the likelihood of reherniation and the need for reoperation in cases involving large annular defects. This implant physically blocks the annulus at the surgical defect, enhancing the surgical outcome for patients at high risk of complications after lumbar discectomy. Composed of a titanium alloy, the device securely anchors into the vertebral body, either caudally or cranially, ensuring stability and effectiveness. By addressing the challenges associated with post-surgical recovery, Barricaid aims to improve patient outcomes and reduce the incidence of further surgeries related to sciatica.

TradeBeam is a provider of Global Trade Management software and services that focuses on streamlining global trading processes for enterprises and their partners. The company offers an integrated solution that enhances import and export compliance and visibility, encompassing inventory management, shipment tracking, and supply chain event management. Additionally, TradeBeam provides global trade finance solutions, including management for open accounts and letters of credit, facilitating smoother international trade operations.

NeuroVista Corporation is a medical device company based in Seattle, Washington, focused on developing innovative technologies for the management and treatment of epilepsy, a condition impacting approximately 3 million individuals in the United States. The company provides advisory technologies designed to reduce the uncertainty surrounding the onset of epileptic seizures, which can vary in severity from brief lapses of awareness to severe convulsions. Founded in 2002 and originally known as BioNeuronics Corporation, NeuroVista rebranded in 2007 to emphasize its commitment to addressing the challenges faced by those affected by epilepsy, a neurological disorder that predominantly affects individuals aged 15 to 64.

Spine Wave, Inc. is a manufacturer of medical devices focused on the treatment of spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company develops and markets a range of innovative products aimed at providing surgical solutions for spine surgeons and their patients. Its offerings include expandable PEEK spacers, interbody devices for posterior surgery, pivoting and lateral spacer systems, and the GraftMag Graft Delivery System for bone graft delivery. Additionally, Spine Wave produces fixation products designed for addressing degeneration, deformity, tumors, and trauma in the thoracolumbar spine, as well as anterior cervical plate systems for spinal fusion from C2-C7 and cervical spacer systems for degenerative disc disease from C2-T1. The company distributes its products through a network of distributors, emphasizing a surgeon-driven approach to product development to address real surgical challenges.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.

Reliance Globalcom, a division of Reliance Communications, leads the global telecommunications operations of India's largest integrated telecom service provider. The company integrates various services, including enterprise solutions, capacity sales, managed services, and a wide range of retail offerings such as global voice, internet solutions, and value-added services. Reliance Globalcom caters to a diverse clientele, serving over 2,100 enterprises, 200 carriers, and approximately 2.2 million retail customers across 163 countries and six continents.

Spine Wave, Inc. is a manufacturer of medical devices focused on the treatment of spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company develops and markets a range of innovative products aimed at providing surgical solutions for spine surgeons and their patients. Its offerings include expandable PEEK spacers, interbody devices for posterior surgery, pivoting and lateral spacer systems, and the GraftMag Graft Delivery System for bone graft delivery. Additionally, Spine Wave produces fixation products designed for addressing degeneration, deformity, tumors, and trauma in the thoracolumbar spine, as well as anterior cervical plate systems for spinal fusion from C2-C7 and cervical spacer systems for degenerative disc disease from C2-T1. The company distributes its products through a network of distributors, emphasizing a surgeon-driven approach to product development to address real surgical challenges.

CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Radiant Medical is a private medical device company based in Redwood City, California, established in 1999. The company specializes in endovascular temperature therapy, focusing on the treatment of heart, brain, and kidney disorders. Its primary product is a single-use central venous heat exchange balloon catheter, which works in conjunction with a heat exchange cassette, a microprocessor-driven controller, and an integrated temperature sensor. This innovative system allows for the safe and rapid reduction, maintenance, and warming of a patient’s core body temperature, enhancing treatment efficacy in critical care settings.

LeftHand Networks Inc. offers data storage systems and IP-based storage area networks (SAN). It offers iSCSI SANs that are composed of multiple storage nodes, pooled together into a single storage system; integrated storage systems; and virtual storage systems. The company also offers evaluation software, such as SAN/iQ software and virtual SAN appliance, which aggregate disparate resources into a single, larger storage system. In addition, it provides IT project solutions, including disaster recovery, business continuance, and data center virtualization; application solutions, including data protection manager, exchange server, sharepoint server, SQL server, and VMware; and industry solutions for education, government, financial services, and healthcare industry. The company offers its products through distributors and resellers in the United States, Canada, and Europe. LeftHand Networks was founded in 1999 and is headquartered in Boulder, Colorado with additional offices in Reading, United Kingdom and Zaltbommel, the Netherlands. As of November 13, 2008, LeftHand Networks Inc. operates as a subsidiary of Hewlett-Packard Company.

Direct Flow Medical is a medical device company focused on developing innovative transcatheter aortic valve replacement systems aimed at treating cardiac valve insufficiency. The company’s flagship product is a percutaneous aortic tissue valve prosthesis designed to offer a safe and effective alternative for patients, particularly those over the age of 65 who suffer from calcified aortic valves. Despite the prevalence of this condition, with approximately 1.2 million affected individuals, only around 150,000 receive surgical treatment annually. Direct Flow Medical's technology enhances patient outcomes and minimizes complications by allowing heart surgeons to perform valve replacements without invasive surgery, using repeated assessments of hemodynamic performance prior to final implantation.

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

Affymax, Inc. is a biopharmaceutical company based in New York, founded in 2001, that focuses on developing novel peptide-based therapeutics aimed at treating serious and life-threatening conditions. The company's primary product, OMONTYS, is an injection designed to treat anemia associated with chronic kidney disease in adult patients on dialysis. OMONTYS is notable for being the only once-monthly erythropoiesis-stimulating agent available for this patient population in the United States. At one point, a New Drug Application for peginesatide, the active component of OMONTYS, was under review by the U.S. Food and Drug Administration, but the company currently does not have significant operations.

Yipes is a data communications services provider. It was acquired in 2007 by Indian telecommunications service provider Reliance Communications. Yipes delivers scalable business-to-business and business-to-Internet IP networking services. Their regional IP network Yipes MAN seamlessly extends your company's LAN to other business locations or to business partner locations. Their Yipes NET Internet service brings the Web to your LAN at breakaway speeds. Yipes NET customers can also take advantage of Yipes' industry-leading security offering Yipes WALL managed firewall service, to safeguard their private information from the dangers of the public Internet. Yipes NAN replaces private line and frame relay services with the simplicity of Ethernet. Yipes WEB offers a full portfolio of Internet management services. Yipes TOUGH enables customers to extend the redundancy on their customer premise to the Yipes Network.

Reliance Globalcom, a division of Reliance Communications, leads the global telecommunications operations of India's largest integrated telecom service provider. The company integrates various services, including enterprise solutions, capacity sales, managed services, and a wide range of retail offerings such as global voice, internet solutions, and value-added services. Reliance Globalcom caters to a diverse clientele, serving over 2,100 enterprises, 200 carriers, and approximately 2.2 million retail customers across 163 countries and six continents.

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.

NeuroBionics Corp. researches and develops medical devices for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, obesity, and depression.

CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.

TradeBeam is a provider of Global Trade Management software and services that focuses on streamlining global trading processes for enterprises and their partners. The company offers an integrated solution that enhances import and export compliance and visibility, encompassing inventory management, shipment tracking, and supply chain event management. Additionally, TradeBeam provides global trade finance solutions, including management for open accounts and letters of credit, facilitating smoother international trade operations.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.

Evolution Benefits specializes in enhancing financial health and employee satisfaction by creating customized employee benefit plans tailored to the specific objectives and goals of their clients. The company takes a comprehensive approach, considering the unique demographics and culture of each organization to develop a cost-effective benefits package. In addition to employee benefits strategies, Evolution Benefits also offers healthcare software and payment solutions that facilitate the administration and management of consumer-directed accounts. Their services include integration solutions for defined contribution plans, Health Savings Accounts, Health Reimbursement Arrangements, Flexible Spending Accounts, Voluntary Employee Beneficiary Associations, Pre-tax Transportation Accounts, wellness plans, and more. Through these offerings, Evolution Benefits aims to streamline the complexities of healthcare for businesses and their employees.

Affymax, Inc. is a biopharmaceutical company based in New York, founded in 2001, that focuses on developing novel peptide-based therapeutics aimed at treating serious and life-threatening conditions. The company's primary product, OMONTYS, is an injection designed to treat anemia associated with chronic kidney disease in adult patients on dialysis. OMONTYS is notable for being the only once-monthly erythropoiesis-stimulating agent available for this patient population in the United States. At one point, a New Drug Application for peginesatide, the active component of OMONTYS, was under review by the U.S. Food and Drug Administration, but the company currently does not have significant operations.

Aspreva Pharmaceuticals Corp, based in Victoria, British Columbia, is a pharmaceutical company dedicated to identifying and developing new indications for existing drugs aimed at underserved patient populations. The company employs a strategy known as "indication partnering," collaborating with other pharmaceutical and biopharmaceutical firms to explore new therapeutic approvals that align with its expertise. Aspreva focuses on complex diseases and specialized patient groups, utilizing a proprietary screening program to identify late-stage and approved medications that may offer significant therapeutic benefits for uncommon conditions. Through partnerships, Aspreva acquires rights to develop these drugs, encompassing clinical research, regulatory approvals, and specialized commercialization efforts tailored to these intricate therapeutic areas.

Spiration, Inc., operating as Olympus Respiratory America, specializes in the development of medical devices aimed at treating air leaks and lung diseases. Founded in 1999 and headquartered in Redmond, Washington, the company focuses on innovative solutions for both acute and chronic lung conditions. One of its key products is the IBV valve system, a minimally invasive device designed to redirect airflow from diseased sections of the lung to healthier areas. This system is particularly beneficial for patients suffering from emphysema, prolonged air leaks, and other complications associated with damaged lungs. As of 2010, Spiration operates as a subsidiary of Olympus America Inc.

NeuroVista Corporation is a medical device company based in Seattle, Washington, focused on developing innovative technologies for the management and treatment of epilepsy, a condition impacting approximately 3 million individuals in the United States. The company provides advisory technologies designed to reduce the uncertainty surrounding the onset of epileptic seizures, which can vary in severity from brief lapses of awareness to severe convulsions. Founded in 2002 and originally known as BioNeuronics Corporation, NeuroVista rebranded in 2007 to emphasize its commitment to addressing the challenges faced by those affected by epilepsy, a neurological disorder that predominantly affects individuals aged 15 to 64.

Visiogen, Inc. is an ophthalmic medical device company focused on developing innovative vision solutions for patients with cataracts, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless range of near, intermediate, and distance vision without the need for glasses or contact lenses. This advanced device is supplied in a pre-loaded injector to minimize lens handling during surgical procedures. Visiogen's technology has received CE Mark approval in Europe and is currently in clinical trials in the United States, aiming to enhance the quality of life for cataract patients through improved vision correction options.

Auxilium Pharmaceuticals, founded in 1999, specializes in the development and marketing of pharmaceutical products primarily aimed at urology and sexual health disorders. The company is committed to improving patient outcomes through the identification, development, and commercialization of innovative specialty biopharmaceuticals. Over the years, Auxilium has expanded its mission to address a broader range of unmet medical needs, focusing on creating novel treatment options that enhance the quality of life for patients dealing with various health challenges.

Storability Software specializes in enterprise storage resource management solutions designed to simplify and centralize the management of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers customers to better understand, manage, and optimize their storage investments. By utilizing Storability Software's offerings, clients can achieve increased asset utilization, improved management efficiency, enhanced quality of service, and greater availability of their storage resources.

Infinera Corporation is a global provider of optical transport networking equipment, software, and services, headquartered in Sunnyvale, California. The company specializes in photonic integration technology, offering a diverse portfolio that includes modular platforms, coherent optical transport systems, and packet-optical transport solutions. Its products, such as the Infinera Groove series and 7300 series, cater to various transport network applications, enabling high-capacity data transmission and management. Infinera's digital transport node system incorporates advanced technology for digital processing of network traffic. The company also provides a range of support services, including technical support, installation, and professional services. Infinera's customer base consists of telecommunications service providers, internet content providers, cable operators, research institutions, large enterprises, and government entities, all of whom rely on its solutions for efficient optical networking. Founded in 2000, Infinera continues to innovate in the field of optical networking, enhancing the capabilities of global communications infrastructure.

Progen Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. The company's products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Redwood City, California. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. As a result of the acquisition of Cellgate, Inc. by Progen Pharmaceuticals Limited, Cellgate's name was changed. As of February 7, 2008, Progen Pharmaceuticals, Inc. operates as a subsidiary of Progen Pharmaceuticals Limited (ASX: PGL).

Ilypsa is a company focused on discovering and developing pharmaceutical products for renal care, specifically targeting complications associated with chronic kidney diseases. Established in 2002 and based in Santa Clara, California, Ilypsa specializes in creating non-absorbed polymeric compounds that act as binders for phosphate and potassium. These compounds work by binding to phosphorus in the digestive tract, preventing its absorption into the body and thereby helping patients manage high blood levels of phosphorus, a condition known as hyperphosphatemia. The company's innovations are aimed at improving the quality of life for individuals suffering from kidney-related health issues.

Evolution Benefits specializes in enhancing financial health and employee satisfaction by creating customized employee benefit plans tailored to the specific objectives and goals of their clients. The company takes a comprehensive approach, considering the unique demographics and culture of each organization to develop a cost-effective benefits package. In addition to employee benefits strategies, Evolution Benefits also offers healthcare software and payment solutions that facilitate the administration and management of consumer-directed accounts. Their services include integration solutions for defined contribution plans, Health Savings Accounts, Health Reimbursement Arrangements, Flexible Spending Accounts, Voluntary Employee Beneficiary Associations, Pre-tax Transportation Accounts, wellness plans, and more. Through these offerings, Evolution Benefits aims to streamline the complexities of healthcare for businesses and their employees.

Sirna Therapeutics is a biotechnology company focused on developing therapies based on RNA interference (RNAi), a groundbreaking scientific discovery with the potential to transform disease treatment. By harnessing the capabilities of RNAi, Sirna Therapeutics aims to create innovative solutions that address various illnesses, positioning itself at the forefront of this emerging field. The company's commitment to advancing RNAi-based therapies highlights its role in the evolving landscape of medical treatment, with the goal of improving patient outcomes through targeted interventions.

LeftHand Networks Inc. offers data storage systems and IP-based storage area networks (SAN). It offers iSCSI SANs that are composed of multiple storage nodes, pooled together into a single storage system; integrated storage systems; and virtual storage systems. The company also offers evaluation software, such as SAN/iQ software and virtual SAN appliance, which aggregate disparate resources into a single, larger storage system. In addition, it provides IT project solutions, including disaster recovery, business continuance, and data center virtualization; application solutions, including data protection manager, exchange server, sharepoint server, SQL server, and VMware; and industry solutions for education, government, financial services, and healthcare industry. The company offers its products through distributors and resellers in the United States, Canada, and Europe. LeftHand Networks was founded in 1999 and is headquartered in Boulder, Colorado with additional offices in Reading, United Kingdom and Zaltbommel, the Netherlands. As of November 13, 2008, LeftHand Networks Inc. operates as a subsidiary of Hewlett-Packard Company.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Watercove Networks is a provider of data networking infrastructure designed specifically for wireless service providers aiming to deploy next-generation mobile data services efficiently and profitably. Established in 2000, the company offers the Mobile Data Service System, which enables operators to accelerate the rollout of high-speed data services in 2.5G and 3G environments. This system addresses the challenges associated with legacy routing-centric networks, facilitating a smooth transition to modern technologies without the need for expensive upgrades. The company is led by a seasoned management team with extensive experience in the telecommunications and data networking sectors, supported by a board of directors comprising industry veterans. Watercove Networks has secured significant financing from reputable investors, allowing it to enhance its innovative solutions and drive growth in the emerging mobile data market.

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.

Barricaid is a medical device company that focuses on developing innovative solutions to prevent repeat disc herniation in patients who have undergone back surgery. The company's flagship product is a bone-anchored implant designed to reduce the likelihood of reherniation and the need for reoperation in cases involving large annular defects. This implant physically blocks the annulus at the surgical defect, enhancing the surgical outcome for patients at high risk of complications after lumbar discectomy. Composed of a titanium alloy, the device securely anchors into the vertebral body, either caudally or cranially, ensuring stability and effectiveness. By addressing the challenges associated with post-surgical recovery, Barricaid aims to improve patient outcomes and reduce the incidence of further surgeries related to sciatica.

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

Supply Solutions is an online based company selling industrial supplies.

Epocrates is a developer of mobile and online clinical information and decision support software aimed at healthcare professionals. The company provides a range of tools, including an integrated diagnostic suite, a comprehensive drug reference guide, and resources for ICD-9 and CPT coding, as well as medical terminology. Additionally, Epocrates offers a free learning center for on-the-go education. With a significant user base, including one-third of U.S. physicians and medical students, Epocrates enables healthcare providers to access critical information quickly and confidently at the point of care, complementing its offerings with market research and formulary hosting services.

Internet Photonics, Inc. is a growth-oriented company specializing in optical Ethernet transport and switching products designed for telecom service providers. The company has developed the first carrier-grade Intelligent Wavelength Platforms, enabling network operators, including service providers and cable multiple system operators (MSOs), to offer high-bandwidth data services in conjunction with their existing legacy services. By focusing on innovative solutions in optical networking, Internet Photonics aims to enhance the capabilities of telecom infrastructure and support the increasing demand for efficient data transmission.

Sensys Medical develops a non-invasive blood glucose monitor that used near-infrared diffuse reflectance spectroscopy.

Blue Falcon provides the most cost-effective, high quality, and easily deployed digital content delivery solutions. With centralized network control, decentralized distribution, and integration with industry leading DRM solutions, Blue Falcon provides groundbreaking digital delivery efficiencies within a securely managed network. Blue Falcon's suite of solutions meets a broad range of digital delivery needs including: live audio and video streaming, on-demand music and movies, and large file and application downloads. The company's target customer base includes digital content providers, traditional/web broadcasters, and Global 1000 corporations. Blue Falcon's rapidly growing customer base includes Radio Free Virgin and Salem Communications. Corporate headquarters are in downtown Los Angeles in the historic Bradbury Building.

Visiogen, Inc. is an ophthalmic medical device company focused on developing innovative vision solutions for patients with cataracts, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless range of near, intermediate, and distance vision without the need for glasses or contact lenses. This advanced device is supplied in a pre-loaded injector to minimize lens handling during surgical procedures. Visiogen's technology has received CE Mark approval in Europe and is currently in clinical trials in the United States, aiming to enhance the quality of life for cataract patients through improved vision correction options.

Storability Software specializes in enterprise storage resource management solutions designed to simplify and centralize the management of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers customers to better understand, manage, and optimize their storage investments. By utilizing Storability Software's offerings, clients can achieve increased asset utilization, improved management efficiency, enhanced quality of service, and greater availability of their storage resources.

Labcyte Inc., founded in 2000 and based in San Jose, California, specializes in developing acoustic droplet ejection (ADE) technology for various applications in the life sciences. The company's innovative approach uses focused beams of acoustic energy to precisely dispense nanoliter-scale droplets of fluid from one plate to another, enabling high accuracy at low volumes and reducing consumables costs. Labcyte's products include automation systems, laboratory workstations, and control software, which are utilized in drug discovery, genomics research, cancer research, and personalized medicine. The company operates as a subsidiary of Beckman Coulter, Inc., with additional offices across multiple countries including Canada, the United Kingdom, Australia, India, South Korea, China, Hong Kong, Japan, Singapore, and Taiwan.

Captura Software, established in September 1994, specializes in offering large companies comprehensive solutions for managing and reducing costs. The company focuses on Total Expense Management solutions that automate expense management through web-based technology, enabling organizations to capture crucial financial data for informed decision-making. These solutions can be deployed globally, accessible to users via standard web browsers with an Internet connection. Captura's applications are centrally hosted and maintained, providing flexibility in deployment options. To further enhance its offerings, Captura forms strategic alliances across various sectors, including finance, software, travel, and communications. These collaborations assist clients in designing and implementing integrated solutions for effective expense data capture and analysis across their enterprises.

Spiration, Inc., operating as Olympus Respiratory America, specializes in the development of medical devices aimed at treating air leaks and lung diseases. Founded in 1999 and headquartered in Redmond, Washington, the company focuses on innovative solutions for both acute and chronic lung conditions. One of its key products is the IBV valve system, a minimally invasive device designed to redirect airflow from diseased sections of the lung to healthier areas. This system is particularly beneficial for patients suffering from emphysema, prolonged air leaks, and other complications associated with damaged lungs. As of 2010, Spiration operates as a subsidiary of Olympus America Inc.

Aurora Networks specializes in the development of optical transport equipment tailored for hybrid fiber coaxial (HFC) networks, which are widely utilized by cable television operators. The company focuses on creating advanced optical transport systems that facilitate the integration of digital broadband, voice, video, and data applications. Aurora's product offerings include headend and hub solutions, power supplies, special application back plates, CWDM Ethernet access systems, optical node products, Wi-Fi equipment, and field passives such as optical splitters and combiners. Additionally, they provide single-channel DWDM optical filters and optical mix modules, all designed to enhance the return on investment for broadband service providers.

Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.

DynamicSoft provides carrier-class infrastructure software for packet-based wireline and wireless communications networks. The company's infrastructure solutions enable carriers and communications application service providers to deploy telephony applications and converged services over Internet protocol-based networks. Its dynamicsoft Service Engine allows mobile carriers to deliver voice and data services over packet network, as well as provides a migration path to various IP 3G network environments; supports various services, such as voice, multimedia messaging, instant messaging, and presence; and consolidates common functions, which include customer data storage, authentication, authorization, provisioning, and service interaction. The company was founded in 1998 and is based in East Hanover, New Jersey.

Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.

Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols such as molecules to create potent medications.

Funded in May 2000, Opthos capitalizes on newly-developed, highly innovative technologies. Their goal is to deliver optical networking products that satisfy the overwhelming need by communications carriers for high agility, very low cost solutions.

Protedyne is a developer of laboratory automation systems, focusing on the pharmaceutical and biotech industries. As a wholly owned subsidiary of Laboratory Corporation of America since May 2007, Protedyne integrates industrial automation principles into diagnostic testing facilities nationwide. The company designs advanced robotic systems characterized by an enclosed platform featuring a 4-axis robotic arm, which enhances workflow efficiency by providing versatility in deck capacity and configuration options. Protedyne's automation systems are engineered to improve data management and process tracking, ensuring effective laboratory operations. The company is ISO 13485:2003 Registered with BSI Management Systems, underscoring its commitment to quality and compliance in its automation technologies.

Storability Software specializes in enterprise storage resource management solutions designed to simplify and centralize the management of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers customers to better understand, manage, and optimize their storage investments. By utilizing Storability Software's offerings, clients can achieve increased asset utilization, improved management efficiency, enhanced quality of service, and greater availability of their storage resources.

Atesto is an automated Web testing service that enables organizations to develop, deploy and monitor Web applications without needing to license, install and manage software and hardware systems and infrastructure. The company’s software suite, Atesto Functional Test, tests and validates complex, static and dynamic Web applications. The company also offers load testing and monitoring services, to address performance and application maintenance needs. The Automated Load Test services simulate complex real-life application scenarios using live Internet traffic from a globally distributed network and the Response Watch service features periodic transaction and Web application monitoring capability from global locations. Both services include detailed, real-time, online reports on application performance and analysis.

Infinera Corporation is a global provider of optical transport networking equipment, software, and services, headquartered in Sunnyvale, California. The company specializes in photonic integration technology, offering a diverse portfolio that includes modular platforms, coherent optical transport systems, and packet-optical transport solutions. Its products, such as the Infinera Groove series and 7300 series, cater to various transport network applications, enabling high-capacity data transmission and management. Infinera's digital transport node system incorporates advanced technology for digital processing of network traffic. The company also provides a range of support services, including technical support, installation, and professional services. Infinera's customer base consists of telecommunications service providers, internet content providers, cable operators, research institutions, large enterprises, and government entities, all of whom rely on its solutions for efficient optical networking. Founded in 2000, Infinera continues to innovate in the field of optical networking, enhancing the capabilities of global communications infrastructure.

MarketFirst Software, Inc. is a company that specializes in developing software and hosted e-marketing solutions for organizations looking to execute marketing campaigns online. Founded in 1996 and based in Mountain View, California, MarketFirst offers a comprehensive e-marketing software platform, along with software templates known as eMarketing Blueprints to assist in campaign creation. Additionally, the company provides a hosted service and offers strategic consulting and implementation services to enhance clients' e-marketing efforts.

Phylos is dedicated to the discovery and development of novel biopharmaceuticals.

Watercove Networks is a provider of data networking infrastructure designed specifically for wireless service providers aiming to deploy next-generation mobile data services efficiently and profitably. Established in 2000, the company offers the Mobile Data Service System, which enables operators to accelerate the rollout of high-speed data services in 2.5G and 3G environments. This system addresses the challenges associated with legacy routing-centric networks, facilitating a smooth transition to modern technologies without the need for expensive upgrades. The company is led by a seasoned management team with extensive experience in the telecommunications and data networking sectors, supported by a board of directors comprising industry veterans. Watercove Networks has secured significant financing from reputable investors, allowing it to enhance its innovative solutions and drive growth in the emerging mobile data market.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.

Supply Solutions is an online based company selling industrial supplies.

Phase Forward is a prominent provider of integrated data management solutions specifically designed for clinical trials and drug safety. Founded in 1997 by Paul Bleicher, M.D., Ph.D., the company aimed to transition life sciences organizations from traditional paper-based methods to innovative, Internet-enabled solutions. Its flagship product, InForm, has significantly advanced electronic data capture, transforming how clinical data is collected, analyzed, and managed. Phase Forward's technology and global services facilitate the automation and integration of the clinical development process, encompassing study initiation, FDA submission, and post-marketing studies. The company's acquisition of Lincoln Technologies enhanced its capabilities, allowing it to offer comprehensive solutions for tracking and monitoring product efficacy and safety, ultimately leading to more efficient and cost-effective trial management. Prior to its acquisition by Oracle in 2010, Phase Forward was headquartered in Waltham, Massachusetts, with additional offices in the UK, Japan, France, and Australia.

Epocrates is a developer of mobile and online clinical information and decision support software aimed at healthcare professionals. The company provides a range of tools, including an integrated diagnostic suite, a comprehensive drug reference guide, and resources for ICD-9 and CPT coding, as well as medical terminology. Additionally, Epocrates offers a free learning center for on-the-go education. With a significant user base, including one-third of U.S. physicians and medical students, Epocrates enables healthcare providers to access critical information quickly and confidently at the point of care, complementing its offerings with market research and formulary hosting services.

Vasca is a medical device company that provides technologies to improve body access for therapeutic interventions in the United States and European Union. The company develops, manufactures, and markets LifeSite, a subcutaneous device that combines a valve with cannulas, which are used for the treatment of chronic renal failure. Vasca was founded in 1996 and is based in Tewksbury, Massachusetts, United States.

Astral Point Communications develops transmission network elements aimed at metropolitan optical access to the internet.

DynamicSoft provides carrier-class infrastructure software for packet-based wireline and wireless communications networks. The company's infrastructure solutions enable carriers and communications application service providers to deploy telephony applications and converged services over Internet protocol-based networks. Its dynamicsoft Service Engine allows mobile carriers to deliver voice and data services over packet network, as well as provides a migration path to various IP 3G network environments; supports various services, such as voice, multimedia messaging, instant messaging, and presence; and consolidates common functions, which include customer data storage, authentication, authorization, provisioning, and service interaction. The company was founded in 1998 and is based in East Hanover, New Jersey.

eFinance's innovative solutions enable companies to quickly and accurately gauge the financial soundness of their customers at each step of the financial supply chain. Their solutions strengthen the credit evaluation process and enable customers to better manage transaction workflow. Customers leverage eFinance technology to increase revenue and profitability while expanding their end customer base and improving customer retention and satisfaction.

MuseumShop.com has established partnerships and affiliations with more than 44 museums worldwide and showcases more than 3,500 products ranging from home decor to fine prints.

Funded in May 2000, Opthos capitalizes on newly-developed, highly innovative technologies. Their goal is to deliver optical networking products that satisfy the overwhelming need by communications carriers for high agility, very low cost solutions.

LiquidPrice.com is a consumer-driven online marketplace where retailers offer brand name products and services in a competitive environment.

CarrierPoint is a developer of web-based logistics software that enhances communication between shippers, carriers, and brokers. Established in 1999 by Cliff Isaacson and John Thomson, the company is headquartered in Georgia. Its software solutions encompass various functionalities, including compliance tools for managing requests for quotes, contract administration, shipment rating, dispatch, scheduling, and freight payment. Additionally, CarrierPoint provides monitoring services such as status tracking, delivery confirmation, and analysis reports. The collaboration features facilitate both planned and unplanned interactions among users, while integration options include OMSI and professional services, allowing seamless management of freight movements within a shipper's back office.

Edupoint specializes in providing a comprehensive data management solution for K-12 education through its Synergy® Education Platform. This platform includes Synergy SIS, a robust student information system, Synergy LMS for learning management and assessment, and Synergy SE for managing special education. By addressing the diverse needs of K-12 school districts, Edupoint enables educators to connect various stakeholders with essential data, thereby enhancing decision-making processes and promoting improved student performance and achievement.

Skila is an internet company providing business intelligence and eKnowledge solutions for the pharmaceutical and biotechnology industries.

Excess Bandwidth Corp. specializes in developing algorithms that facilitate the connection of Internet voice and data services across multiple devices using copper twisted-pair wires. The company is recognized for creating technology that complies with the G.shdsl/HDSL2 high-speed symmetric DSL specification, which allows for the efficient transmission of high-speed voice and data over a single pair of wires. Established in 1998, Excess Bandwidth is a privately held company that focuses on designing symmetrical digital subscriber line physical-layer chips and mixed signal semiconductors for communications processors. Through its innovative solutions, the company aims to enhance high-bandwidth communications.

BrightLink Networks, Inc. is a manufacturer of optical network switching systems. The company begins the marketing and manufacturing of its intelligent optical network system.

Tavolo offers an online store that enables its users to find and buy products related to cooking. Tavolo was acquired by OurHouse in December 2000. It is based in San Rafael, California.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

BravoGifts.com is the first e-commerce site tailored exclusively to the needs of the business gift market. BravoGifts.com provides the highest levels of service to its customers through: selection - the widest selection of business gifts available anywhere; gift advice and services - advice and information on business gifts, gift searching, unique gift selection tools, and business gift etiquette; and convenience - everything is centralized in one easily accessible Internet location. The company boasts the broadest collection of brilliant business gifts from executive toys and gadgets, to golf and weekend getaways, theater and sports tickets, and gourmet foods.